How Long Does Tirzepatide Stay in Your System?

This question rarely comes up out of curiosity. It comes up when someone is stopping, switching, scheduling surgery, or planning a pregnancy. The answer starts with one number, and for tirzepatide that number is smaller than most people expect.

Quick Answer

As of September 26, 2026, the prescribing information for approved tirzepatide products gives an elimination half-life of about five days, which is what makes once-weekly dosing possible. Medications are generally considered cleared after roughly five half-lives, so tirzepatide is largely gone about 25 days after a final dose. That is an average from pharmacokinetic studies, not a guarantee for one person.

What a Five-Day Half-Life Means

Half-life is the time it takes for the amount of a medication in the body to fall by half. It is the single most useful number for understanding how a medication behaves, and it explains three things patients notice.

Why the injection is weekly. A medication that halves over five days can be given once a week and still hold a workable level. The schedule follows from the chemistry rather than from convenience.

Why week two feels different from week eight. With any repeatedly dosed medication, levels climb until the amount leaving each week matches the amount going in. That plateau, called steady state, is why the same dose can feel different early and later.

Why a missed dose does not reset anything. After a skipped week, a substantial share of the previous dose is still present. What to do about a missed dose is a question for the prescriber rather than for arithmetic, but the medication has not disappeared.

Clearance After a Final Dose

This is the standard five-half-lives arithmetic applied to the labeled half-life, and it is an approximation for a typical adult. Only your own clinician can say how it applies to you, and anyone who needs a precise answer for a medical reason should get it from them.

Tirzepatide Versus Semaglutide

This is the comparison people actually want, and it is a fair one to make because both figures come from the same kind of source: the prescribing information for the approved products.

The semaglutide labeling goes further and states directly that the medication will be present in circulation for about five weeks after the last dose. Tirzepatide clears the faster of the two.

That difference matters in three practical places: a shorter washout when a prescriber plans a switch, a shorter tail of side effects after stopping, and a different conversation before a procedure. It is not a reason to prefer one medication over the other. Which one suits a person depends on their history, and that is the physician's call. Our companion piece covers how long semaglutide stays in your system.

Compounded medications are not FDA-approved as final products and have not been evaluated by the FDA for safety, effectiveness, or quality. The half-life figures above come from the labeling of the approved products and describe the molecule.

The Three Situations Behind This Question

Stopping treatment

Levels fall over weeks rather than at once, so appetite is not expected to change overnight; your prescriber can tell you what to expect. Digestive effects follow their own timeline, and tirzepatide constipation covers the one that most often outlasts the first month. Tiredness after stopping or changing treatment has its own pattern, covered in does tirzepatide make you tired. Weight regain after stopping GLP-1 treatment is common and well documented, which is a separate subject we cover in keeping weight off after GLP-1. If you are considering stopping, the conversation to have is with the prescriber, before rather than after.

Surgery or a procedure

Tell the surgical and anaesthesia teams that you take a GLP-1 medication, and tell them early rather than on the morning. These medications slow stomach emptying, which is the reason anaesthesia teams ask. Whether to pause, and for how long, is set by those teams together with your prescriber. It is not a calculation to do at home, and this article deliberately gives no interval.

Planning a pregnancy

The labeling for approved GLP-1 products addresses use in pregnancy, and the timing of stopping before trying to conceive is a decision for the prescriber and, where relevant, an obstetric clinician. Bring the date of your last dose: it is the piece of information they need and the one only you have.

What This Number Is Not

It is not a schedule for restarting, a licence to change a dose, or a way to time a switch without telling anyone. It is one input a clinician uses among several. The useful thing you can do with it is arrive at the conversation knowing your last dose date and roughly where you sit on the curve.

What the primary sources say

• DailyMed, MOUNJARO (tirzepatide) prescribing information, section 10 Overdosage (accessed September 26, 2026): "A period of observation and treatment for these symptoms may be necessary, taking into account the half-life of tirzepatide of approximately 5 days."
• DailyMed, ZEPBOUND (tirzepatide) prescribing information, Highlights, Warnings and Precautions (accessed September 26, 2026): "Pulmonary Aspiration During General Anesthesia or Deep Sedation: Has been reported in patients receiving GLP-1 receptor agonists undergoing elective surgeries or procedures. Instruct patients to inform healthcare providers of any planned surgeries or procedures."
• DailyMed, OZEMPIC (semaglutide) prescribing information, section 12.3 Pharmacokinetics (accessed September 26, 2026): "With an elimination half-life of approximately 1 week, semaglutide will be present in the circulation for about 5 weeks after the last dose."
• MedlinePlus Drug Information, Tirzepatide injection (accessed September 26, 2026): "if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking tirzepatide."

Telehealth prescribing rules differ by state. Read the state-by-state guide.